Statement Of Financial Position [Abstract]

PCI Biotech Holding - Filing #5867918

Concept	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Right-of-use assets	—	—	310,000 NOK	—	—	—	—	297,000 NOK	—	—	—	—
Non-current assets	—	—	310,000 NOK	—	—	—	—	297,000 NOK	—	—	—	—
Current assets [abstract]
Trade and other current receivables	—	—	3 836 NOK	—	—	—	—	2 570 NOK	—	—	—	—
Cash and cash equivalents	—	—	27 069 NOK	—	—	—	—	41 184 NOK	56 596 NOK	—	—	—
Current assets	—	—	30 905 NOK	—	—	—	—	43 753 NOK	—	—	—	—
Assets	—	—	31 215 NOK	—	—	—	—	44 050 NOK	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	1 119 NOK	—	—	—	—	1 119 NOK	—	—	—	—
Retained earnings	—	—	- NOK	—	—	—	—	- NOK	—	—	—	—
Equity	- NOK	22 333 NOK	23 453 NOK	1 119 NOK	1 119 NOK	37 923 NOK	- NOK	39 043 NOK	57 403 NOK	111 979 NOK	54 577 NOK	- NOK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	—	—	- NOK	—	—	—	—	34,000 NOK	—	—	—	—
Current liabilities [abstract]
Current liabilities	—	—	7 762 NOK	—	—	—	—	4 974 NOK	—	—	—	—
Liabilities	—	—	7 762 NOK	—	—	—	—	5 008 NOK	—	—	—	—
Equity and liabilities	—	—	31 215 NOK	—	—	—	—	44 050 NOK	—	—	—	—